Hudson Livestock Supplements, Inc. – Trademark Portfolio
Entity Type: 03
Hudson Livestock Supplements, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HLS and EQUINE MAX. The owner is based in Miles, TX.
8193 Thompson Rd.
Miles, TX 76861
Showing of trademarks Trademarks
Trademark Classifications
Hudson Livestock Supplements, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Hudson Livestock Supplements, Inc. have?
Hudson Livestock Supplements, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does Hudson Livestock Supplements, Inc. file in?
Hudson Livestock Supplements, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hudson Livestock Supplements, Inc.'s most well-known trademarks?
Hudson Livestock Supplements, Inc.'s registered trademark portfolio includes well-known marks such as HLS and EQUINE MAX. These are among 2 currently registered trademarks in the portfolio.
What is Hudson Livestock Supplements, Inc.'s trademark registration success rate?
Hudson Livestock Supplements, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.